ArticleThe British journal of radiology2018

T3 subclassification using the EMD/mesorectum ratio predicts neoadjuvant chemoradiation outcome in T3 rectal cancer patients.

Lijun Shen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.